Supplements for caregivers
Family caregivers — caring for a partner, parent, or child with chronic illness or dementia — have measurably worse health outcomes than non-caregivers. The supplement stack supports a small slice of that. Most of the work is non-supplement.
The caregiver stack — rationale by ingredient
Vitamin D3 1,000–2,000 IU/day
Caregivers spend more time indoors than the general population; deficiency rates are accordingly higher. Mood and immune-function benefits are foundational. Test 25-OH-D if possible.
Magnesium glycinate 300–400 mg in the evening
Magnesium intake is below recommended in most adults; chronic stress depletes magnesium status further. The glycinate form is well-tolerated, supports sleep, and reduces subjective tension. It is the unglamorous backbone of a stress stack.
Omega-3 (EPA-predominant) 1,000 mg EPA/day for adjunctive mood support
The meta-analytic evidence for EPA-predominant omega-3 in depression is consistent. Caregiver depression rates are roughly 2–3× the general population; omega-3 is reasonable adjunctive to therapy and lifestyle changes. Not a substitute for professional mental-health care if depression is significant.
L-Theanine 200 mg during high-acute-stress moments
Acute stress (the hospital admission, the difficult care interaction) responds to 200–400 mg L-theanine taken 30–60 minutes before the stressor. Reduces cortisol response without sedation. Particularly useful for caregivers who don't want benzodiazepines but need acute support.
Low-dose melatonin 0.3–0.5 mg for sleep-onset insomnia from fragmented schedules
Caregiver sleep is heavily fragmented (overnight monitoring, early-morning caregiving, on-call status). Low-dose melatonin supports circadian alignment in the limited windows you have for sleep. The high-dose OTC versions (5–10 mg) sedate without realigning the clock and increase next-day grogginess — exactly what you don't need.
Saffron 30 mg/day as a mood adjunct
Multiple RCTs support saffron as a mild-moderate depression adjunct with effect sizes approaching some prescription antidepressants. Reasonable trial in mild caregiver depression as adjunct to therapy. Take it with prescriber awareness if on antidepressants — additive serotonergic effects.
Glycine 3 g at bedtime for sleep quality
For caregivers whose problem is poor sleep quality and next-day fatigue (rather than sleep onset), glycine has the cleaner trial evidence than melatonin. Cheap, well-tolerated, taste is mildly sweet, dissolves easily in water.
Creatine 3–5 g/day for cognitive performance under sleep restriction
Recent meta-analyses support creatine's cognitive effects, particularly under sleep deprivation — the caregiver-specific use case. Also preserves muscle mass during the inevitable physical-activity reduction of intensive caregiving.
What to skip
- Ashwagandha (despite the stress marketing) if you have thyroid disease or autoimmune disease — real thyroid effects and theoretical autoimmune flare risk. Magnesium and glycine are cleaner alternatives for stress-related sleep.
- "Adrenal fatigue" or "stress relief" multi-ingredient complexes — adrenal fatigue is not a recognized clinical entity; the complexes typically include subtherapeutic doses of legitimate ingredients (ashwagandha, rhodiola, eleuthero).
- High-dose 5-HTP or SAMe for depression without prescriber input — serotonergic interactions with prescription antidepressants are real and can be dangerous.
- "Mood and energy" stimulant blends with caffeine, synephrine, theobromine — caregivers don't need higher heart rate at 3am.
- Diphenhydramine ("PM" sleep aids) — chronic anticholinergic burden is associated with cognitive impairment in older caregivers; not appropriate for chronic use.
- Substituting supplements for clinician care — caregivers consistently neglect their own healthcare. Annual physical, mental-health check-in, and treating your own chronic conditions matter more than any pill stack.
Sources
- Vitaliano PP, et al. Is caregiving hazardous to one's physical health? A meta-analysis. Psychol Bull. 2003;129(6):946–972. PMID: 14599289
- Pinquart M, Sörensen S. Differences between caregivers and noncaregivers in psychological health and physical health: a meta-analysis. Psychol Aging. 2003;18(2):250–267. PMID: 12825775
- Hidese S, et al. Effects of L-theanine administration on stress-related symptoms and cognitive functions in healthy adults. Nutrients. 2019;11(10):2362. PMID: 31623400
- Hausenblas HA, et al. Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis. J Integr Med. 2013;11(6):377–383. PMID: 24299602
- Mocking RJT, et al. Meta-analysis and meta-regression of omega-3 polyunsaturated fatty acid supplementation for major depressive disorder. Transl Psychiatry. 2016;6(3):e756. PMID: 26978738
- Bannai M, Kawai N. New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. J Pharmacol Sci. 2012;118(2):145–148. PMID: 22293292